{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T12:12:40Z","timestamp":1793621560400,"version":"4.5.0"},"reference-count":138,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.mayocp.2018.10.011","type":"journal-article","created":{"date-parts":[[2019,3,25]],"date-time":"2019-03-25T10:22:10Z","timestamp":1553509330000},"page":"1048-1064","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Thyrotoxicosis: Diagnosis and Management"],"prefix":"10.1016","volume":"94","author":[{"given":"Anu","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius N.","family":"Stan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.mayocp.2018.10.011_bib1","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.mayocp.2018.10.011_bib2","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1210\/jcem.87.2.8182","article-title":"Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)","volume":"87","author":"Hollowell","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.mayocp.2018.10.011_bib3","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2265.1977.tb01340.x","article-title":"The spectrum of thyroid disease in a community: the Whickham survey","volume":"7","author":"Tunbridge","year":"1977","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"10.1016\/j.mayocp.2018.10.011_bib4","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1210\/jc.2008-2291","article-title":"Prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review","volume":"94","author":"Golden","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.mayocp.2018.10.011_bib5","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1089\/105072501300176417","article-title":"Environmental iodine intake affects the type of nonmalignant thyroid disease","volume":"11","author":"Laurberg","year":"2001","journal-title":"Thyroid"},{"issue":"6","key":"10.1016\/j.mayocp.2018.10.011_bib6","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1530\/EJE-11-0548","article-title":"Incidence of hyperthyroidism in Sweden","volume":"165","author":"Abraham-Nordling","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.mayocp.2018.10.011_bib7","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3109\/00365513.2013.769623","article-title":"Incidence rate of symptomatic painless thyroiditis presenting with thyrotoxicosis in Denmark as evaluated by consecutive thyroid scintigraphies","volume":"73","author":"Schwartz","year":"2013","journal-title":"Scand J Clin Lab Invest"},{"issue":"4","key":"10.1016\/j.mayocp.2018.10.011_bib8","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1001\/archinte.1980.00330160038023","article-title":"Lymphocytic thyroiditis with spontaneously resolving hyperthyroidism (silent thyroiditis)","volume":"140","author":"Nikolai","year":"1980","journal-title":"Arch Intern Med"},{"issue":"suppl 1","key":"10.1016\/j.mayocp.2018.10.011_bib9","first-page":"114","article-title":"Grave's disease 1835-2002","volume":"59","author":"Weetman","year":"2003","journal-title":"Horm Res"},{"key":"10.1016\/j.mayocp.2018.10.011_bib10","series-title":"Collections From the Unpublished Medical Writings of the Late Caleb Hillier Parry","first-page":"478","author":"Parry","year":"1845"},{"key":"10.1016\/j.mayocp.2018.10.011_bib11","series-title":"Clinical Lectures on the Practice of Medicine","author":"Graves","year":"1864"},{"key":"10.1016\/j.mayocp.2018.10.011_bib12","first-page":"197","article-title":"Exophthalmos durch Hypertrophie des Zellgewebes in der Augenhohle","volume":"6","author":"Von Basedow","year":"1840","journal-title":"Wchenscher Heilkunde"},{"issue":"4","key":"10.1016\/j.mayocp.2018.10.011_bib13","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S2213-8587(14)70225-6","article-title":"Iodine deficiency and thyroid disorders","volume":"3","author":"Zimmermann","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"12","key":"10.1016\/j.mayocp.2018.10.011_bib14","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1210\/jc.2006-1402","article-title":"Influences of age, gender, smoking, and family history on autoimmune thyroid disease phenotype","volume":"91","author":"Manji","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.mayocp.2018.10.011_bib15","first-page":"930","article-title":"Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts","volume":"86","author":"Brix","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1-2","key":"10.1016\/j.mayocp.2018.10.011_bib16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.mce.2010.01.013","article-title":"Genetics of thyroid autoimmunity and the role of the TSHR","volume":"322","author":"Brand","year":"2010","journal-title":"Mol Cell Endocrinol"},{"issue":"9","key":"10.1016\/j.mayocp.2018.10.011_bib17","first-page":"3182","article-title":"HLA-DRB1*08, DRB1*03\/DRB3*0101, and DRB3*0202 are susceptibility genes for Graves' disease in North American Caucasians, whereas DRB1*07 is protective","volume":"84","author":"Chen","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.mayocp.2018.10.011_bib18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1146\/annurev-pathol-012513-104713","article-title":"Mechanisms of autoimmune thyroid diseases: from genetics to epigenetics","volume":"9","author":"Tomer","year":"2014","journal-title":"Annu Rev Pathol"},{"issue":"2","key":"10.1016\/j.mayocp.2018.10.011_bib19","first-page":"185","article-title":"Graves' disease [letter]","volume":"376","author":"Smith","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.mayocp.2018.10.011_bib20","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s40618-014-0214-2","article-title":"Role of genetic and non-genetic factors in the etiology of Graves' disease","volume":"38","author":"Marin\u00f2","year":"2015","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"6","key":"10.1016\/j.mayocp.2018.10.011_bib21","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/00004728-197903060-00019","article-title":"Appearance of Graves' disease on orbital computed tomography","volume":"3","author":"Enzmann","year":"1979","journal-title":"J\u00a0Comput Assist Tomogr"},{"issue":"3","key":"10.1016\/j.mayocp.2018.10.011_bib22","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0002-9394(14)70276-4","article-title":"Clinical features of Graves' ophthalmopathy in an incidence cohort","volume":"121","author":"Bartley","year":"1996","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.mayocp.2018.10.011_bib23","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.beem.2011.10.001","article-title":"Thyroid dermopathy and acropachy","volume":"26","author":"Fatourechi","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.mayocp.2018.10.011_bib24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.autrev.2012.07.003","article-title":"TSH receptor autoantibody immunoassay in patients with Graves' disease: improvement of diagnostic accuracy over different generations of methods; systematic review and meta-analysis","volume":"12","author":"Tozzoli","year":"2012","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.mayocp.2018.10.011_bib25","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1046\/j.1365-2265.2001.01347.x","article-title":"TSH-receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goitre: a comparison of two competitive binding assays","volume":"55","author":"Pedersen","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.mayocp.2018.10.011_bib26","first-page":"120","article-title":"Use of color Doppler ultrasonography to measure thyroid blood flow and differentiate Graves' disease from painless thyroiditis","volume":"2","author":"Hiraiwa","year":"2013","journal-title":"Eur Thyroid J"},{"issue":"6","key":"10.1016\/j.mayocp.2018.10.011_bib27","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/0002-9343(82)90778-1","article-title":"Hyperthyroxinemia in patients treated with high-dose propranolol","volume":"73","author":"Cooper","year":"1982","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.mayocp.2018.10.011_bib28","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1210\/jcem-41-2-354","article-title":"Acute effects of corticosteroids on thyroid activity in Graves' disease","volume":"41","author":"Williams","year":"1975","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.mayocp.2018.10.011_bib29","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1210\/jc.2013-1954","article-title":"Comparative effectiveness of therapies for Graves' hyperthyroidism: a systematic review and network meta-analysis","volume":"98","author":"Sundaresh","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.mayocp.2018.10.011_bib30","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1210\/jc.2015-4274","article-title":"Antithyroid drug side effects in the population and in pregnancy","volume":"101","author":"Andersen","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.mayocp.2018.10.011_bib31","doi-asserted-by":"crossref","first-page":"e0180108","DOI":"10.1371\/journal.pone.0180108","article-title":"Effects of methimazole and propylthiouracil exposure during pregnancy on the risk of neonatal congenital malformations: a meta-analysis","volume":"12","author":"Song","year":"2017","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.mayocp.2018.10.011_bib32","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1089\/thy.2005.15.1279","article-title":"Graves' disease: a long-term quality-of-life follow up of patients randomized to treatment with antithyroid drugs, radioiodine, or surgery","volume":"15","author":"Abraham-Nordling","year":"2005","journal-title":"Thyroid"},{"issue":"5","key":"10.1016\/j.mayocp.2018.10.011_bib33","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1210\/jcem-13-5-548","article-title":"Functional and histologic effects of therapeutic doses of radioactive iodine on the thyroid of man","volume":"13","author":"Dobyns","year":"1953","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.mayocp.2018.10.011_bib34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/cen.12688","article-title":"A\u00a02013 European survey of clinical practice patterns in the management of Graves' disease","volume":"84","author":"Bartalena","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"10.1016\/j.mayocp.2018.10.011_bib35","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1210\/jc.2012-2802","article-title":"A\u00a02011 survey of clinical practice patterns in the management of Graves' disease","volume":"97","author":"Burch","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.mayocp.2018.10.011_bib36","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1089\/thy.2016.0222","article-title":"Antithyroid drugs\u2014the most common treatment for Graves' disease in the United States: a nationwide population-based study [letter]","volume":"26","author":"Brito","year":"2016","journal-title":"Thyroid"},{"issue":"7","key":"10.1016\/j.mayocp.2018.10.011_bib37","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1089\/thy.2009.0169","article-title":"The role of propylthiouracil in the management of Graves' disease in adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration","volume":"19","author":"Bahn","year":"2009","journal-title":"Thyroid"},{"issue":"4","key":"10.1016\/j.mayocp.2018.10.011_bib38","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/cen.12478","article-title":"Block & replace regime versus titration regime of antithyroid drugs for the treatment of Graves' disease: a retrospective observational study","volume":"81","author":"Vaidya","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"10.1016\/j.mayocp.2018.10.011_bib39","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1210\/jc.2006-2135","article-title":"Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease","volume":"92","author":"Nakamura","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.mayocp.2018.10.011_bib40","doi-asserted-by":"crossref","first-page":"281","DOI":"10.7326\/0003-4819-121-4-199408150-00010","article-title":"Treatment of hyperthyroid disease","volume":"121","author":"Klein","year":"1994","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.mayocp.2018.10.011_bib41","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1089\/thy.2016.0343","article-title":"Comparative effectiveness of treatment choices for Graves' hyperthyroidism: a historical cohort study","volume":"27","author":"Sundaresh","year":"2017","journal-title":"Thyroid"},{"issue":"10","key":"10.1016\/j.mayocp.2018.10.011_bib42","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/BF03346433","article-title":"Long-term follow-up of patients with hyperthyroidism due to Graves' disease treated with methimazole: comparison of usual treatment schedule with drug discontinuation vs continuous treatment with low methimazole doses; a retrospective study","volume":"31","author":"Mazza","year":"2008","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"1","key":"10.1016\/j.mayocp.2018.10.011_bib43","first-page":"CD003420","article-title":"Antithyroid drug regimen for treating Graves' hyperthyroidism","author":"Abraham","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.mayocp.2018.10.011_bib44","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/BF03343979","article-title":"Does smoking increase relapse rates in Graves' disease?","volume":"25","author":"Kimball","year":"2002","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"3","key":"10.1016\/j.mayocp.2018.10.011_bib45","first-page":"1038","article-title":"Age and gender predict the outcome of treatment for Graves' hyperthyroidism","volume":"85","author":"Allahabadia","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.mayocp.2018.10.011_bib46","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1089\/thy.2006.16.295","volume":"16","author":"Carella","year":"2006","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.mayocp.2018.10.011_bib47","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1365-2265.2012.04365.x","article-title":"Hepatotoxicity and cutaneous reactions after antithyroid drug administration","volume":"77","author":"Otsuka","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.mayocp.2018.10.011_bib48","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/bcp.12336","article-title":"Antithyroid drug-related hepatotoxicity in hyperthyroidism patients: a population-based cohort study","volume":"78","author":"Wang","year":"2014","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"10.1016\/j.mayocp.2018.10.011_bib49","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1089\/thy.2016.0652","article-title":"Long-term antithyroid drug treatment: a systematic review and meta-analysis","volume":"27","author":"Azizi","year":"2017","journal-title":"Thyroid"},{"issue":"12","key":"10.1016\/j.mayocp.2018.10.011_bib50","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1089\/thy.2015.0195","article-title":"Outcomes in relapsed Graves' disease patients following radioiodine or prolonged low dose of methimazole treatment","volume":"25","author":"Villagelin","year":"2015","journal-title":"Thyroid"},{"issue":"9","key":"10.1016\/j.mayocp.2018.10.011_bib51","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1089\/thy.2011.0039","article-title":"Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy","volume":"21","author":"Laurberg","year":"2011","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.mayocp.2018.10.011_bib52","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1089\/thy.2010.0181","article-title":"Outcome of very long-term treatment with antithyroid drugs in Graves' hyperthyroidism associated with Graves' orbitopathy","volume":"21","author":"Elbers","year":"2011","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.mayocp.2018.10.011_bib53","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0889-8529(03)00010-0","article-title":"Perioperative management of the thyrotoxic patient","volume":"32","author":"Langley","year":"2003","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"3","key":"10.1016\/j.mayocp.2018.10.011_bib54","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1245\/s10434-014-4077-8","article-title":"Preventing postoperative hypocalcemia in patients with Graves disease: a prospective study","volume":"22","author":"Oltmann","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.mayocp.2018.10.011_bib55","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/00000658-199809000-00005","article-title":"The importance of surgeon experience for clinical and economic outcomes from thyroidectomy","volume":"228","author":"Sosa","year":"1998","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.mayocp.2018.10.011_bib56","doi-asserted-by":"crossref","first-page":"405","DOI":"10.7326\/M17-1398","article-title":"Antithyroid drugs and congenital malformations: a nationwide Korean cohort study","volume":"168","author":"Seo","year":"2018","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.mayocp.2018.10.011_bib57","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1089\/thy.2016.0457","article-title":"2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum","volume":"27","author":"Alexander","year":"2017","journal-title":"Thyroid"},{"issue":"10","key":"10.1016\/j.mayocp.2018.10.011_bib58","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1089\/thy.2014.0150","article-title":"Severity of birth defects after propylthiouracil exposure in early pregnancy","volume":"24","author":"Andersen","year":"2014","journal-title":"Thyroid"},{"issue":"11","key":"10.1016\/j.mayocp.2018.10.011_bib59","first-page":"3885","article-title":"Somatic mutations in the thyrotropin receptor gene and not in the Gs\u03b1 protein gene in 31 toxic thyroid nodules","volume":"82","author":"F\u00fchrer","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.mayocp.2018.10.011_bib60","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1210\/jcem.82.12.4441","article-title":"Identification of constitutively activating somatic thyrotropin receptor mutations in a subset of toxic multinodular goiters","volume":"82","author":"Holzapfel","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.mayocp.2018.10.011_bib61","first-page":"2695","article-title":"Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gs\u03b1 genes as a cause of toxic thyroid adenomas","volume":"82","author":"Parma","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.mayocp.2018.10.011_bib62","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2796.1991.tb00368.x","volume":"229","author":"Laurberg","year":"1991","journal-title":"J\u00a0Intern Med"},{"issue":"4","key":"10.1016\/j.mayocp.2018.10.011_bib63","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1365-2265.2007.02920.x","article-title":"Proportion of type 1 and type 2 amiodarone-induced thyrotoxicosis has changed over a 27-year period in Italy","volume":"67","author":"Bogazzi","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.mayocp.2018.10.011_bib64","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1530\/eje.0.1460283","article-title":"Managing toxic thyroid adenoma: a cost-effectiveness analysis","volume":"146","author":"Vidal-Trecan","year":"2002","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"10.1016\/j.mayocp.2018.10.011_bib65","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1089\/thy.2004.14.933","article-title":"Radioiodine or surgery for toxic thyroid adenoma: dissecting an important decision; a cost-effectiveness analysis","volume":"14","author":"Vidal-Trecan","year":"2004","journal-title":"Thyroid"},{"issue":"7","key":"10.1016\/j.mayocp.2018.10.011_bib66","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1210\/jc.2012-1063","article-title":"Risk of hypothyroidism following hemithyroidectomy: systematic review and meta-analysis of prognostic studies","volume":"97","author":"Verloop","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.mayocp.2018.10.011_bib67","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1210\/jc.2015-3997","article-title":"Hypothyroidism following hemithyroidectomy: incidence, risk factors, and clinical characteristics","volume":"101","author":"Ahn","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.mayocp.2018.10.011_bib68","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2265.2005.02218.x","article-title":"Outcome of radioiodine-131 therapy in hyperfunctioning thyroid nodules: a 20 years' retrospective study","volume":"62","author":"Ceccarelli","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.mayocp.2018.10.011_bib69","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1046\/j.1365-2265.1999.00635.x","article-title":"Long-term effect of radioactive iodine on thyroid function and size in patients with solitary autonomously functioning toxic thyroid nodules","volume":"50","author":"Nygaard","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"10.1016\/j.mayocp.2018.10.011_bib70","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1089\/thy.1998.8.277","article-title":"Treatment of patients with toxic multinodular goiter","volume":"8","author":"Erickson","year":"1998","journal-title":"Thyroid"},{"issue":"6","key":"10.1016\/j.mayocp.2018.10.011_bib71","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1067\/msy.2002.128691","article-title":"Current treatment of nodular goiter with hyperthyroidism (Plummer's disease): surgery versus radioiodine","volume":"132","author":"Kang","year":"2002","journal-title":"Surgery"},{"issue":"10","key":"10.1016\/j.mayocp.2018.10.011_bib72","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s12149-011-0526-7","article-title":"Treatment of autonomously functioning thyroid nodules at a single institution: radioiodine therapy, surgery, and ethanol injection therapy","volume":"25","author":"Yano","year":"2011","journal-title":"Ann Nucl Med"},{"issue":"5","key":"10.1016\/j.mayocp.2018.10.011_bib73","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1210\/jc.2014-4077","article-title":"Comparative efficacy of radiofrequency and laser ablation for the treatment of benign thyroid nodules: systematic review including traditional pooling and Bayesian network meta-analysis","volume":"100","author":"Ha","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.mayocp.2018.10.011_bib74","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.hrthm.2007.07.020","article-title":"A\u00a0practical guide for clinicians who treat patients with amiodarone: 2007","volume":"4","author":"Goldschlager","year":"2007","journal-title":"Heart Rhythm"},{"issue":"9","key":"10.1016\/j.mayocp.2018.10.011_bib75","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1093\/clinchem\/35.9.1882","article-title":"Amiodarone and the thyroid","volume":"35","author":"Kennedy","year":"1989","journal-title":"Clin Chem"},{"issue":"2","key":"10.1016\/j.mayocp.2018.10.011_bib76","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2165\/00003088-198409020-00002","article-title":"Clinical pharmacokinetics of amiodarone","volume":"9","author":"Latini","year":"1984","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"10.1016\/j.mayocp.2018.10.011_bib77","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1210\/jcem-62-3-563","article-title":"Iodine kinetic studies during amiodarone treatment","volume":"62","author":"Rao","year":"1986","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.mayocp.2018.10.011_bib78","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2265.1985.tb03238.x","article-title":"Amiodarone and thyroid hormone action","volume":"22","author":"Franklyn","year":"1985","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"10.1016\/j.mayocp.2018.10.011_bib79","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1001\/archinte.1993.00410070068010","article-title":"Thyrotoxicosis followed by hypothyroidism in patients treated with amiodarone: a possible consequence of a destructive process in the thyroid","volume":"153","author":"Roti","year":"1993","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.mayocp.2018.10.011_bib80","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1210\/jcem-32-4-515","article-title":"Enhanced susceptibility to iodide myxedema in patients with Hashimoto's disease","volume":"32","author":"Braverman","year":"1971","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.mayocp.2018.10.011_bib81","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1089\/thy.1998.8.83","article-title":"Iodine-induced hyperthyroidism: occurrence and epidemiology","volume":"8","author":"Stanbury","year":"1998","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.mayocp.2018.10.011_bib82","doi-asserted-by":"crossref","first-page":"28","DOI":"10.7326\/0003-4819-101-1-28","article-title":"Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy","volume":"101","author":"Martino","year":"1984","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.mayocp.2018.10.011_bib83","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1210\/jc.2010-0180","article-title":"Approach to the patient with amiodarone-induced thyrotoxicosis","volume":"95","author":"Bogazzi","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.mayocp.2018.10.011_bib84","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1530\/EJE-14-0267","article-title":"The onset time of amiodarone-induced thyrotoxicosis (AIT) depends on AIT type","volume":"171","author":"Tomisti","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"10.1016\/j.mayocp.2018.10.011_bib85","first-page":"2930","article-title":"Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study","volume":"81","author":"Bartalena","year":"1996","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.mayocp.2018.10.011_bib86","first-page":"423","article-title":"Serum interleukin-6 in amiodarone-induced thyrotoxicosis","volume":"78","author":"Bartalena","year":"1994","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.mayocp.2018.10.011_bib87","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/BF03347021","article-title":"Thyroid color flow doppler sonography and radioiodine uptake in 55 consecutive patients with amiodarone-induced thyrotoxicosis","volume":"26","author":"Bogazzi","year":"2003","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"1071","key":"10.1016\/j.mayocp.2018.10.011_bib88","doi-asserted-by":"crossref","first-page":"20160836","DOI":"10.1259\/bjr.20160836","article-title":"Evaluation of 99mTc-MIBI in thyroid gland imaging for the diagnosis of amiodarone-induced thyrotoxicosis","volume":"90","author":"Wang","year":"2017","journal-title":"Br J Radiol"},{"issue":"4","key":"10.1016\/j.mayocp.2018.10.011_bib89","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1530\/EJE-08-0348","article-title":"The usefulness of 99mTc-sestaMIBI thyroid scan in the differential diagnosis and management of amiodarone-induced thyrotoxicosis","volume":"159","author":"Piga","year":"2008","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"10.1016\/j.mayocp.2018.10.011_bib90","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1210\/jc.2012-1797","article-title":"Total thyroidectomy in patients with amiodarone-induced thyrotoxicosis and severe left ventricular systolic dysfunction","volume":"97","author":"Tomisti","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.mayocp.2018.10.011_bib91","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00268-004-7599-6","article-title":"Surgical management of amiodarone-associated thyrotoxicosis: Mayo Clinic experience","volume":"28","author":"Houghton","year":"2004","journal-title":"World J Surg"},{"issue":"4","key":"10.1016\/j.mayocp.2018.10.011_bib92","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1530\/EJE-14-0144","article-title":"The incidence rate of pituitary adenomas in western Sweden for the period 2001-2011","volume":"171","author":"Tj\u00f6rnstrand","year":"2014","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"10.1016\/j.mayocp.2018.10.011_bib93","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1210\/jc.2010-0537","article-title":"Incidence of pituitary adenomas in Northern Finland in 1992-2007","volume":"95","author":"Raappana","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.mayocp.2018.10.011_bib94","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s12020-016-0863-3","article-title":"Thyrotropin-secreting pituitary adenomas: epidemiology, diagnosis, and management","volume":"52","author":"Amlashi","year":"2016","journal-title":"Endocrine"},{"issue":"4","key":"10.1016\/j.mayocp.2018.10.011_bib95","doi-asserted-by":"crossref","first-page":"R183","DOI":"10.1530\/EJE-16-1029","article-title":"DIAGNOSIS OF ENDOCRINE DISEASE: Diagnostic approach to TSH-producing pituitary adenoma","volume":"177","author":"Tj\u00f6rnstrand","year":"2017","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.mayocp.2018.10.011_bib96","first-page":"1462","article-title":"Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases","volume":"121","author":"Yamada","year":"2014","journal-title":"J\u00a0Neurosurg"},{"issue":"1","key":"10.1016\/j.mayocp.2018.10.011_bib97","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1507\/endocrj.K06-133","article-title":"Expression of type 5 somatostatin receptor in TSH-secreting pituitary adenomas: a possible marker for predicting long-term response to octreotide therapy","volume":"54","author":"Yoshihara","year":"2007","journal-title":"Endocr J"},{"issue":"6","key":"10.1016\/j.mayocp.2018.10.011_bib98","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1210\/jcem.86.6.7593","article-title":"Efficacy of the long-acting octreotide formulation (octreotide-LAR) in patients with thyrotropin-secreting pituitary adenomas","volume":"86","author":"Caron","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.mayocp.2018.10.011_bib99","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1210\/jcem.85.4.6548","article-title":"Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotide","volume":"85","author":"Kuhn","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.mayocp.2018.10.011_bib100","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1210\/jcem.84.2.5505","article-title":"Thyrotropin-secreting pituitary tumors: diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health","volume":"84","author":"Brucker-Davis","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.mayocp.2018.10.011_bib101","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1210\/jc.2013-4376","article-title":"Thyrotropin-secreting pituitary adenomas: outcome of pituitary surgery and irradiation","volume":"99","author":"Malchiodi","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.mayocp.2018.10.011_bib102","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1038\/bjc.2011.139","article-title":"Hyperthyroidism and human chorionic gonadotrophin production in gestational trophoblastic disease","volume":"104","author":"Walkington","year":"2011","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.mayocp.2018.10.011_bib103","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/annonc\/mdp265","article-title":"Prevalence of paraneoplastic hyperthyroidism in patients with metastatic non-seminomatous germ-cell tumors","volume":"21","author":"Oosting","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.mayocp.2018.10.011_bib104","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4103\/abr.abr_160_17","article-title":"A\u00a0case of functional metastatic follicular thyroid carcinoma that presented with hip fracture and hypercalcemia","volume":"7","author":"Karimifar","year":"2018","journal-title":"Adv Biomed Res"},{"issue":"12","key":"10.1016\/j.mayocp.2018.10.011_bib105","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1507\/endocrj.EJ17-0220","article-title":"A\u00a0case of metastatic follicular thyroid carcinoma complicated with Graves' disease after total thyroidectomy","volume":"64","author":"Aoyama","year":"2017","journal-title":"Endocr J"},{"issue":"11","key":"10.1016\/j.mayocp.2018.10.011_bib106","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1089\/thy.2015.0167","article-title":"Rapid control of T3 thyrotoxicosis in patients with metastatic follicular thyroid cancer treated with lenvatinib [letter]","volume":"25","author":"Danilovic","year":"2015","journal-title":"Thyroid"},{"issue":"5","key":"10.1016\/j.mayocp.2018.10.011_bib107","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1089\/thy.2009.0460","article-title":"Fractionated radioiodine therapy for hyperthyroidism caused by widespread metastatic follicular thyroid carcinoma [letter]","volume":"20","author":"Nishihara","year":"2010","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.mayocp.2018.10.011_bib108","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1590\/S0004-27302010000100013","article-title":"Hyperfunctioning thyroid cancer: a five-year follow-up","volume":"54","author":"Azevedo","year":"2010","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"6","key":"10.1016\/j.mayocp.2018.10.011_bib109","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1210\/jc.2007-2282","article-title":"3,5,3'-Triiodothyronine thyrotoxicosis due to increased conversion of administered levothyroxine in patients with massive metastatic follicular thyroid carcinoma","volume":"93","author":"Miyauchi","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.mayocp.2018.10.011_bib110","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1365-2265.1994.tb03942.x","article-title":"Metastatic thyroid cancer presenting as thyrotoxicosis: report of three cases","volume":"40","author":"Kasagi","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.mayocp.2018.10.011_bib111","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0020-7292(93)90628-A","article-title":"Struma ovarii","volume":"42","author":"Ayhan","year":"1993","journal-title":"Int J Gynaecol Obstet"},{"issue":"3","key":"10.1016\/j.mayocp.2018.10.011_bib112","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0090-8258(03)00141-0","article-title":"Malignant struma ovarii: a case report and analysis of cases reported in the literature with focus on survival and I131 therapy","volume":"89","author":"DeSimone","year":"2003","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.mayocp.2018.10.011_bib113","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0889-8529(05)70305-4","article-title":"Syndromes of thyrotoxicosis with low radioactive iodine uptake","volume":"27","author":"Ross","year":"1998","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"26","key":"10.1016\/j.mayocp.2018.10.011_bib114","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1056\/NEJMra021194","article-title":"Thyroiditis","volume":"348","author":"Pearce","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.mayocp.2018.10.011_bib115","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/archinte.1981.00340120063014","article-title":"Lymphocytic thyroiditis with spontaneously resolving hyperthyroidism and subacute thyroiditis: long-term follow-up","volume":"141","author":"Nikolai","year":"1981","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.mayocp.2018.10.011_bib116","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1210\/edrv.22.5.0441","article-title":"Postpartum thyroiditis and autoimmune thyroiditis in women of childbearing age: recent insights and consequences for antenatal and postnatal care","volume":"22","author":"Muller","year":"2001","journal-title":"Endocr Rev"},{"issue":"3","key":"10.1016\/j.mayocp.2018.10.011_bib117","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/ajcp\/100.3.200","article-title":"Postpartum thyroiditis: a clinical, histologic, and immunopathologic study of 15 cases","volume":"100","author":"Mizukami","year":"1993","journal-title":"Am J Clin Pathol"},{"issue":"418","key":"10.1016\/j.mayocp.2018.10.011_bib118","first-page":"305","article-title":"Clinical aspects of recurrent postpartum thyroiditis","volume":"47","author":"Lazarus","year":"1997","journal-title":"Br J Gen Pract"},{"issue":"1","key":"10.1016\/j.mayocp.2018.10.011_bib119","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1210\/jcem.85.1.6227","article-title":"Postpartum thyroiditis and long-term thyroid status: prognostic influence of thyroid peroxidase antibodies and ultrasound echogenicity","volume":"85","author":"Premawardhana","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.mayocp.2018.10.011_bib120","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/00003081-199703000-00010","article-title":"Postpartum thyroid dysfunction","volume":"40","author":"Browne-Martin","year":"1997","journal-title":"Clin Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.mayocp.2018.10.011_bib121","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1210\/jc.2006-1821","article-title":"The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies","volume":"92","author":"Negro","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.mayocp.2018.10.011_bib122","doi-asserted-by":"crossref","first-page":"725410","DOI":"10.1155\/2013\/725410","article-title":"Tyrosine kinase inhibitors induced thyroid dysfunction: a review of its incidence, pathophysiology, clinical relevance, and treatment","volume":"2013","author":"Ahmadieh","year":"2013","journal-title":"Biomed Res Int"},{"issue":"2","key":"10.1016\/j.mayocp.2018.10.011_bib123","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/annonc\/mdm483","article-title":"Thyroid function test abnormalities in patients with metastatic renal cell carcinoma treated with sorafenib","volume":"19","author":"Tamaskar","year":"2008","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.mayocp.2018.10.011_bib124","doi-asserted-by":"crossref","first-page":"660","DOI":"10.7326\/0003-4819-145-9-200611070-00008","article-title":"Hypothyroidism after sunitinib treatment for patients with gastrointestinal stromal tumors","volume":"145","author":"Desai","year":"2006","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.mayocp.2018.10.011_bib125","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/cen.13297","article-title":"Thyroid abnormalities following the use of cytotoxic T-lymphocyte antigen-4 and programmed death receptor protein-1 inhibitors in the treatment of melanoma","volume":"86","author":"Morganstein","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"10.1016\/j.mayocp.2018.10.011_bib126","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1210\/jc.2016-2300","article-title":"Incidence of thyroid-related adverse events in melanoma patients treated with pembrolizumab","volume":"101","author":"de Filette","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.mayocp.2018.10.011_bib127","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1210\/jc.2017-00448","article-title":"Pembrolizumab-induced thyroiditis: comprehensive clinical review and insights into underlying involved mechanisms","volume":"102","author":"Delivanis","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.mayocp.2018.10.011_bib128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"issue":"8","key":"10.1016\/j.mayocp.2018.10.011_bib129","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/archinte.165.8.831","article-title":"Thyrotoxicosis caused by weight-reducing herbal medicines","volume":"165","author":"Ohye","year":"2005","journal-title":"Arch Intern Med"},{"issue":"10","key":"10.1016\/j.mayocp.2018.10.011_bib130","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1089\/thy.2013.0101","article-title":"Thyroxine and triiodothyronine content in commercially available thyroid health supplements","volume":"23","author":"Kang","year":"2013","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.mayocp.2018.10.011_bib131","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0002-9343(88)90002-2","article-title":"Community outbreak of thyrotoxicosis: epidemiology, immunogenetic characteristics, and long-term outcome","volume":"84","author":"Kinney","year":"1988","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.mayocp.2018.10.011_bib132","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/thy.1993.3.101","article-title":"The measurement of fecal thyroxine in the diagnosis of thyrotoxicosis factitia","volume":"3","author":"Bouillon","year":"1993","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.mayocp.2018.10.011_bib133","doi-asserted-by":"crossref","first-page":"112","DOI":"10.7326\/0003-4819-118-2-199301150-00006","article-title":"The use of bile acid sequestrants to lower serum thyroid hormones in iatrogenic hyperthyroidism","volume":"118","author":"Shakir","year":"1993","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.mayocp.2018.10.011_bib134","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1056\/NEJMc1602096","article-title":"Biotin treatment mimicking Graves' disease [letter]","volume":"375","author":"Kummer","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.mayocp.2018.10.011_bib135","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1001\/jamainternmed.2016.9295","article-title":"Biotin-induced biochemical Graves disease: a teachable moment","volume":"177","author":"Sharma","year":"2017","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.mayocp.2018.10.011_bib136","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1210\/jc.2004-1430","article-title":"Glucocorticoids decrease thyrotropin-releasing hormone messenger ribonucleic acid expression in the paraventricular nucleus of the human hypothalamus","volume":"90","author":"Alkemade","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9-10","key":"10.1016\/j.mayocp.2018.10.011_bib137","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1515\/jpem-2012-0075","article-title":"TSH suppression after intravenous glucocorticosteroid administration in preterm infants","volume":"25","author":"Shimokaze","year":"2012","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.mayocp.2018.10.011_bib138","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1210\/jc.2006-2388","article-title":"B\u00a0lymphocyte depletion with the monoclonal antibody rituximab in Graves' disease: a controlled pilot study","volume":"92","author":"El Fassi","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619618307997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619618307997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:30:29Z","timestamp":1758418229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619618307997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":138,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0025619618307997"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2018.10.011","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thyrotoxicosis: Diagnosis and Management","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2018.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}